
Cullinan Therapeutics Investor Relations Material
Latest events

Status Update
Cullinan Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Cullinan Therapeutics Inc
Access all reports
Cullinan Oncology Inc, is a clinical-stage biopharmaceutical company focused on developing innovative cancer therapies. Leveraging a modality-agnostic approach, Cullinan Oncology is dedicated to discovering and developing medicines for high-impact oncology targets. The company's strategy involves rigorous and rapid advancement of highly differentiated molecules, resulting in a robust and diversified pipeline of oncology and immuno-oncology therapies. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Cullinan Therapeutics Inc


Status Update
Cullinan Therapeutics Inc


Status Update
Cullinan Therapeutics Inc
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
CGEM
Country
🇺🇸 United States